CD BioSciences, a specialized research service provider, has been at the forefront of scientific advancements for decades. We focus on providing preclinical solutions that deliver client studies with responsiveness, flexibility, and customized approaches. By delving into different therapeutic areas, we help clients understand the challenges faced in each and explore potential avenues for pharmaceutical intervention.
Neurodegenerative Diseases
Cardiovascular Diseases
Cerebrovascular Diseases
Cancers
Bone Diseases
Liver Diseases
Macular Degeneration
Hearing Loss
Age-related neurodegenerative diseases (NDs), including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD), are characterized by the progressive degeneration of neurons, leading to cognitive decline and motor impairments. CD BioSciences actively assists our clients in preclinical research to unravel the underlying mechanisms and develop novel therapeutic strategies. Our comprehensive capabilities also encompass various stages of the drug development process, from early target identification to preclinical efficacy and safety assessments.
Explore Our Preclinical Neurodegenerative Disease R&D ServicesCardiovascular diseases (CVDs), such as coronary artery disease and heart failure (HF), are major causes of morbidity and mortality worldwide, particularly in aging populations. A focus of CD BioSciences is to help clients study age-related changes in the cardiovascular system, including arterial stiffness, endothelial dysfunction, and impaired cardiac function. Our services are aimed at helping clients identify novel therapeutic targets and develop drugs and health care to mitigate the impact of aging on cardiovascular health.
Explore Our Preclinical Cardiovascular Disease R&D ServicesAge-related cerebrovascular diseases, such as ischemic stroke and cerebral small vessel disease (CSVD), contribute to cognitive decline and vascular dementia. CD BioSciences is committed to advancing the understanding of these conditions and developing innovative drugs. Furthermore, we also specialize in developing and customizing experimental models that faithfully mimic the pathological features of cerebrovascular diseases.
Explore Our Preclinical Cerebrovascular Disease R&D ServicesAging is a significant risk factor for the development of various types of cancer. As the global population continues to age, there is an urgent need to explore novel therapeutic approaches to combat age-related cancers. CD BioSciences is actively involved in preclinical research to address this challenge. Our comprehensive services encompass from pathogenesis analysis, biomarker identification, and disease model customization, to drug discovery and development.
Explore Our Preclinical Cancer R&D ServicesAge-related bone diseases, including osteoporosis (OP) and osteoarthritis (OA), significantly impact the quality of life for older individuals. CD BioSciences recognizes the importance of bone disease research and offers comprehensive preclinical services to assess novel drugs and health care. Additionally, our multidisciplinary team of experts works closely with clients to tailor disease models based on specific research objectives, ensuring high fidelity and translational relevance.
Explore Our Preclinical Bone Disease R&D ServicesLiver diseases, such as non-alcoholic fatty liver disease (NAFLD) and cirrhosis, exhibit a strong association with aging. CD BioSciences recognizes the growing burden of age-related liver disease and is committed to advancing research in this area. We help clients conduct comprehensive preclinical studies to understand the pathogenesis of liver disease and evaluate potential pharmaceutical interventions. Our goal is to identify novel targets for drug development, including anti-inflammatory agents, antioxidants, and modulators of liver fibrosis.
Explore Our Preclinical Liver Disease R&D ServicesAge-related macular degeneration (AMD) is the leading cause of vision loss in older adults. CD BioSciences is dedicated to helping clients unravel the complex mechanisms of AMD and develop innovative drugs and health care to preserve vision. By leveraging our expertise in pathogenesis analysis, biomarker identification, disease model customization services, drug discovery and development, as well as healthcare product R&D, we aim to make significant strides in combating this debilitating disease.
Explore Our Preclinical Macular Degeneration R&D ServicesHearing loss is a prevalent age-related condition that can significantly impact an individual's quality of life. Through investigating the underlying mechanisms of age-related hearing loss (ARHL), including hemorheological abnormalities, mitochondrial genes, and immune dysfunction, CD BioSciences aims to help clients identify potential targets and develop therapeutic strategies.
Explore Our Preclinical Hearing Loss R&D Services
CD BioScience is a research service provider focused on aging research, specializing in providing research on aging mechanisms, preclinical drug discovery and development, and the development of healthcare and skincare products.
Copyright © 2024 CD BioSciences. All rights reserved.
